A randomised, double-blind, placebo-controlled parallel group study in IPF patients over 12 weeks evaluating efficacy, safety and tolerability of BI 1015550 taken orally.

  • Glaspole, Ian (Primary Chief Investigator (PCI))
  • Symons, Karen M. (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date15/09/2031/12/22

Keywords

  • Idiopathic pulmonary fibrosis
  • Respiratory medicine
  • Clinical trial